Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2/3
×
INDUSTRY
×
Epstein-Barr Virus Infections
×
Clear all
Filters
3
NCT05305040
2024-05-16
Prevent
AlloVir
Phase 2/3
Terminated
451 enrolled
10 charts
NCT04693637
2024-05-09
Prevent
AlloVir
Phase 2/3
Completed
26 enrolled
16 charts